tiprankstipranks
Renovaro Biosciences (RENB)
NASDAQ:RENB
Holding RENB?
Track your performance easily

Renovaro Biosciences (RENB) Financial Statements

134 Followers

Renovaro Biosciences Financial Overview

Renovaro Biosciences's market cap is currently ―. The company's EPS TTM is $-0.929; its P/E ratio is -0.54; Renovaro Biosciences is scheduled to report earnings on May 15, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit----$ 61.22K
EBIT$ -44.21M$ -73.52M$ -17.19M$ -4.25M$ -9.00M
EBITDA$ -44.16M$ -73.40M$ -17.19M$ -4.22M$ -8.97M
Net Income Common Stockholders$ -44.21M$ -49.92M$ -17.02M$ -4.53M$ -9.18M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 220.57K$ 220.47K$ 312.70K$ 243.98K$ 523.47K
Total Assets$ 121.83M$ 163.13M$ 212.28M$ 58.02M$ 57.56M
Total Debt$ 3.82M$ 3.79M$ 8.57M$ 7.39M$ 4.60M
Net Debt$ 3.60M$ 3.57M$ 8.26M$ 7.15M$ 4.07M
Total Liabilities$ 23.75M$ 31.15M$ 43.68M$ 14.42M$ 10.82M
Stockholders Equity$ 98.09M$ 131.98M$ 168.60M$ 43.60M$ 46.75M
Cash Flow-
Free Cash Flow$ -2.02M$ -2.44M-$ -3.19M$ -2.78M
Operating Cash Flow$ -2.02M$ -2.41M$ -2.63M$ -3.15M$ -2.78M
Investing Cash Flow-$ -53.37K$ -91.60K$ -57.33K$ -1.06M
Financing Cash Flow$ 2.03M$ 2.47M$ 2.64M$ 2.85M$ 2.56M
Currency in USD

Renovaro Biosciences Earnings and Revenue History

Renovaro Biosciences Debt to Assets

Renovaro Biosciences Cash Flow

Renovaro Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis